Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Gut microbe derived metabolite trimethylamine N oxide activates PERK to drive fibrogenic mesenchymal differentiation: iScience The Role of Microbiome in Cardiovascular Health: Insights for Primary Care Interventions Cureus Carnitine, Choline, Cancer and Cholesterol: The TMAO Connection YouTube Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target